首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1166512

2022-2029 年全球球囊後凸成形術器械市場

Global Balloon Kyphoplasty Devices Market - 2022-2029

出版日期: 2022年11月30日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

球囊後凸成形術設備的全球市場規模將在 2021 年達到 6.072 億美元，在 2029 年達到 8.943 億美元，預測期內（2022-2029 年）的複合年增長率為 5.81%。預計還會增長。

球囊後凸成形術是一種微創手術，旨在通過穩定骨折來修復椎骨壓縮性骨折 (VCF)。它治療由骨質疏鬆症、癌症和良性病變引起的椎體病理性骨折。與椎體成形術不同的球囊後凸成形術的主要優點是，在用球囊後凸成形術治療骨折期間，椎體的高度得以恢復。

市場動態

球囊後凸成形術設備市場骨質疏鬆症的日益流行正在推動全球對球囊後凸成形術設備的需求。

預計骨質疏鬆症患病率上升和研發活動增加將推動市場增長。

骨質疏鬆症和骨質疏鬆性骨折是世界範圍內的主要公共衛生問題。當骨密度降低時，骨質疏鬆症就會發展，身體會更快地吸收骨組織，並且可用於替代骨組織的產品更少。根據國際骨質疏鬆症基金會 2020，骨質疏鬆症是 VCF 的主要原因，每年導致超過 890 萬例骨折，或每 3 秒發生一次骨質疏鬆性骨折。骨質疏鬆性椎體壓縮性骨折 (OVCF) 是一個主要的健康問題，會降低生活質量並增加背痛。骨質疏鬆症約佔椎骨壓縮性骨折的 85%。在美國，骨質疏鬆症會降低生活質量並增加與骨質疏鬆症相關的骨折。約有 800 萬女性患有骨質疏鬆症，約有 2200 萬女性有患骨質疏鬆症的風險。美國每年診斷出約 700,000 例椎骨骨折，其中 115,000 例入院治療。在美國，至少有二分之一的女性和四分之一的男性患有骨質疏鬆症相關的骨折。骨質疏鬆症每年導致 200 萬例骨折和 190 億美元的相關費用。到 2025 年，骨質疏鬆症預計每年將導致大約 300 萬例骨折，並造成 253 億美元的損失。

椎體壓縮性骨折 (VCF) 也是由轉移性骨病、轉移性脊柱腫瘤、多發性骨髓瘤和外傷引起的。 VCF 患者接受椎體成形術或骨盆成形術以改善症狀。球囊後凸成形術 (KP) 是一種通過將充氣球囊插入椎骨並使其膨脹來恢復椎骨高度的方法。球囊裝置的使用不同於椎板成形術。通過將球囊逐漸充氣並置入器械，可恢復椎體骨折前的形狀和高度。因此，預計在預測期內，對椎骨骨折診斷和治療的需求不斷增長將推動全球市場。

此外，設備技術進步的加快、各大公司加大研發投入以及各大公司之間的戰略聯盟也是推動球囊椎體後凸成形術設備市場全球增長的因素。. 例如，總部位於美國佛羅裡達州的 PanMed 推出了 CurvePlus，這是一種曲線提升設備，可實現最簡單、最快速、最完整的曲線提升程序。該設備已獲得 FDA 批准，是唯一可以通過彎曲針頭用球囊和骨水泥填充受損椎骨的設備。

水泥洩漏風險、球囊成形術意識低下以及嚴格的監管指南預計會阻礙市場增長。

行業分析

根據各種行業因素，包括波特五力、監管分析、供應鏈分析、價格分析、流行病學、未滿足的需求、報銷方案和技術創新，預測全球球囊後凸成形術設備市場將增長。我們提供詳細的分析。

內容

第1章研究方法與範圍

調查方法
調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第4章市場動態

市場影響因素
司機
約束因素
商機
影響分析

第5章行業分析

波特的五力分析
流行病學
監管分析
保險報銷場景
創新
供應鏈分析
定價分析
未滿足的需求

第 6 章組件

骨骼訪問工具
用於骨折復位的球囊和充氣裝置
骨水泥和水泥供應
其他配件

第 7 章最終用戶

醫院和診所
門診手術中心 (ASC)
其他

第8章按地區

北美
- 美國
- 加拿大
- 墨西哥
歐洲
南美洲
亞太地區
中東和非洲

第9章競爭格局

競爭場景
市場定位/市場份額分析
併購分析

第10章公司簡介

美敦力
- 公司概況
- 產品組合和說明
- 主要亮點
- 財務摘要
Stryker
Johnson & Johnson（DePuy Synthes）
Cook Medical
Zimmer Biomet
CareFusion（BD）
Tecres
Bone Support
AOI Medical
Benvenue Medical

第11章球囊後凸成形術設備的全球市場-DataM

簡介目錄

Product Code: DMMD2041

Market Overview

The global balloon kyphoplasty devices market size was valued US$ 607.2 million in 2021 and is estimated to reach US$ 894.3 million by 2029, growing at a CAGR of 5.81% during the forecast period (2022-2029).

Balloon kyphoplasty is a minimally invasive procedure intended to repair vertebral compression fractures (VCFs) by stabilizing the fractures. It treats pathological fractures of the vertebral body due to osteoporosis, cancer, or benign lesions. The main advantage of balloon kyphoplasty that differentiates it from vertebroplasty is that the vertebral height is restored while treating the fracture through balloon Kyphoplasty.

Market Dynamics

The balloon kyphoplasty devices market is driven by the rising prevalence of osteoporosis, which increases the demand for balloon kyphoplasty devices globally.

Increasing prevalence of osteoporosis and rising R&D activities are expected to drive market growth.

Osteoporosis the and osteoporotic fractures are a major public health problem globally. Osteoporosis develops, density decreases, and the body reabsorbs more bone tissue and produces less to replace it. According to the International Osteoporosis Foundation 2020, osteoporosis is the main cause of VCF, which causes more than 8.9 million fractures each year, i.e., one osteoporotic fracture every three seconds. Osteoporotic vertebral compression fractures (OVCF) comprise a major health problem that decreases life quality and increases back pain. Osteoporosis accounts for about 85% of overall VCF cases. In the US, it decreases life quality and increases seoporosis-related fractures. About eight million women have osteoporosis, and about 22 million are at risk of developing the disease. Around 700,000 vertebral body fractures are diagnosed annually in the US, with 115,000 being admitted to hospitals for treatment. At least one in two women and one in four men in the US suffer from osteoporosis-related fractures. Osteoporosis is responsible for two million broken bones and $19 billion in related costs every year. By 2025, it is predicted that osteoporosis will be responsible for approx.-three million fractures and US$25.3 billion in costs annually.

Vertebral compression fractures (VCF) are also caused by metastatic bone disease, metastatic spinal tumors, multiple myeloma, and traumatic injuries. Individuals with VCF undergo either vertebroplasty or kyphoplasty to rectify the condition. Balloon kyphoplasty (KP) is a procedure wherein a deflated balloon is inserted into the vertebral body through the pedicle and then inflated to restore the height of a collapsed vertebral body. The usage of balloon devices makes kyphoplasty different from vertebroplasty. The gradual inflation of balloon and devices insertion helps restore the pre-facture shape and height of the vertebral bodies. Hence, the rising demand for the diagnosis and treatment of vertebral fractures is projected to drive the global market during the forecast period.

Besides, growing technological advancements in the devices, increasing R&D investment by major players, and strategic alliances among major companies are some of the other factors boosting the growth of the balloon kyphoplasty devices market globally. For instance, PanMed U.S., based in Florida, launched the CurvePlus, a curved kyphoplasty device that allows the simplest, quickest, most complete curved kyphoplasty procedure. It is FDA approved and is only one that permits both balloon and cement to pass through curved needle to fill injured vertebra.

Risk of cement leakage and unawareness are expected to hamper the market growth.

The risk of cement leakage and rare occurrence of stroke, low awareness towards balloon kyphoplasty and stringent regulatory guidelines are expected to hinder the growth of the market.

Industry Analysis

The global balloon kyphoplasty devices market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis, pricing analysis, epidemiology, unmet needs, reimbursement scenario and technological innovations.

Segment Analysis

Balloon and inflation devices segment is expected to hold the largest market share in global balloon kyphoplasty devices market

On the basis of component type, the global balloon kyphoplasty devices market is segmented into balloons & inflation devices, bone access tools, bone cement & delivery systems, and accessories. Among these, balloon and inflation devices for recovery of fractures accounted for the largest market share due to the rising demand for these devices in complicated fracture cases. In addition, manufacturers are innovating new technologically advanced products, which are contributing to the major share of this segment during the forecast period.

Medtronic has launched the new Kyphon Xpander II IBT System, which includes the Kyphon Xpander II Inflatable Bone Tamp (IBT) and the Kyphon Inflation Syringe manufactured by Medtronic is used for the treatment of vertebral compression fractures. It is combined with the Kyphon Inflation Syringe, which provides ease of use to customers for use during a balloon kyphoplasty procedure.

Geographical Analysis

North America region holds the largest market share in the global balloon kyphoplasty devices market

North America holds the dominant market share for balloon kyphoplasty devices. Due to the rising number of vertebral compression fracture cases in the U.S., growing geriatric population, technological advancement in balloon kyphoplasty devices, it is expected to maintain the growth over the forecast period well-established health care infrastructure, and high diagnosis & treatment rates of fractures. Osteoporosis, a condition characterized by low bone mass and deterioration in the microarchitecture of bone tissue, causes more than 700,000 spinal fractures each year in the U.S. (2019). The prevalence of osteoporosis is projected to rise in the United States from approximately 13 million people to more than 16 million people by 2022. Though osteoporosis is mostly associated with women, it is also diagnosed in men, who account for an estimated 1 in 5 Americans who have osteoporosis. According to the Centers for Disease Control and Prevention (2021), in the US, 5.1% of men (65 years of age & over) are diagnosed with osteoporosis of the femur neck or lumbar spine, and 24.5% of women 65 years of age & over are diagnosed with osteoporosis of the femur neck or lumbar spine. With the rising number of osteoporosis cases in this region, the demand for diagnosis and treatment is increasing, which results in the e growth of the balloon kyphoplasty market in this region.

Competitive Landscape

The balloon kyphoplasty devices market is highly competitive with presence of large number of players including Medtronic, Stryker, Johnson & Johnson (DePuy Synthes), Cook Medical, Zimmer Biomet, CareFusion, Tecres, Bone Support, AOI Medical, and Benvenue Medical.

The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the balloon kyphoplasty devices market globally. For instance,

In Sep 2022, Aurora Spine Corporation announced approval of its novel lumbar spinal stenosis by FDA. Indicating its usage with Aurora ZIP Platform.
In Jul 2022, Zavation Medical Products announced approval of its novel expandable lumbar interbody fusion device, eZspand Lateral by FDA.
In Jun 2022, Onkos surgical announced agreement with Stryker for acquiring Juvenile Tumour System, a prosthetic system for bone cancer pediatric patients.
In Jun 2022, Stryker announced approval of Q guidance system by FDA. It is advance planning guidance system that is intra-operative and is utilized during spinal surgery.
In May 2021, Safe Orthopaedics, a company offering innovative ranges of sterile implants combined with their single-use instruments for back surgery, announced CE mark approval for its novel treatment for osteoporotic patients known as Hickory.

Key Companies to Watch

Medtronic:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio:

Kyphon Balloon Kyphoplasty: With the help of orthopaedic balloons, it restores correct angular deformity and vertebral height from the vertebral compression fractures that are cause due to cancer, osteoporosis and benign lesion.

Key Developments: In May 2020, Medtronic announced U.S. launch of kyphon assisted directional cannula for using it with balloon kyphoplasty products for the treatment of vertebral compression fractures due to cancer and osteoporosis.

The global balloon kyphoplasty devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

4.1. Market Impacting Factors
4.2. Drivers
4.3. Restraints
4.4. Opportunity
4.5. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Epidemiology
5.3. Regulatory Analysis
5.4. Reimbursement Scenario
5.5. Technological Innovations
5.6. Supply Chain Analysis
5.7. Pricing Analysis
5.8. Unmet Needs

6. By Component

6.1. Introduction
- 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component Segment
- 6.1.2. Market Attractiveness Index, By Component Segment
6.2. Bone access tools
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Balloons and inflation devices for fracture reduction
6.4. Bone cement and cement delivery
6.5. Other accessories

7. By End-User

7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
- 7.1.2. Market Attractiveness Index, By End-User Segment
7.2. Hospitals & Clinics
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ambulatory Surgical Centers (ASCs)
7.4. Others

8. By Region

8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
- 8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.3. Europe
8.4. South America
8.5. Asia Pacific
8.6. The Middle East and Africa

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Medtronic
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Key Highlights
- 10.1.4. Financial Overview
10.2. Stryker
10.3. Johnson & Johnson (DePuy Synthes)
10.4. Cook Medical
10.5. Zimmer Biomet
10.6. CareFusion (BD)
10.7. Tecres
10.8. Bone Support
10.9. AOI Medical
10.10. Benvenue Medical

LIST NOT EXHAUSTIVE